Bank of America’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $30.5M | Sell |
8,682,907
-2,838,753
| -25% | -$11.6M | ﹤0.01% | 2021 |
|
|
2025
Q4 | $38.8M | Sell |
11,521,660
-173,884
| -1% | -$452K | ﹤0.01% | 1733 |
|
|
2025
Q3 | $15.3M | Buy |
11,695,544
+8,337,672
| +248% | +$8.63M | ﹤0.01% | 2861 |
|
|
2025
Q2 | $2.41M | Buy |
3,357,872
+1,929,356
| +135% | +$1.51M | ﹤0.01% | 4612 |
|
|
2025
Q1 | $2.1M | Buy |
1,428,516
+750,371
| +111% | +$1.79M | ﹤0.01% | 4641 |
|
|
2024
Q4 | $3M | Buy |
678,145
+258,372
| +62% | +$1.05M | ﹤0.01% | 4084 |
|
|
2024
Q3 | $1.73M | Sell |
419,773
-292,614
| -41% | -$1.57M | ﹤0.01% | 4666 |
|
|
2024
Q2 | $4.64M | Sell |
712,387
-193,902
| -21% | -$1.37M | ﹤0.01% | 3681 |
|
|
2024
Q1 | $7.89M | Buy |
906,289
+219,523
| +32% | +$2.66M | ﹤0.01% | 3204 |
|
|
2023
Q4 | $7.86M | Sell |
686,766
-110,860
| -14% | -$1.1M | ﹤0.01% | 3142 |
|
|
2023
Q3 | $7.68M | Buy |
797,626
+60,348
| +8% | +$591K | ﹤0.01% | 2993 |
|
|
2023
Q2 | $7.84M | Sell |
737,278
-318,831
| -30% | -$3.43M | ﹤0.01% | 2956 |
|
|
2023
Q1 | $11.1M | Buy |
1,056,109
+122,998
| +13% | +$1.38M | ﹤0.01% | 2719 |
|
|
2022
Q4 | $11.6M | Buy |
933,111
+283,011
| +44% | +$3.21M | ﹤0.01% | 2541 |
|
|
2022
Q3 | $6.73M | Buy |
650,100
+255,130
| +65% | +$2.89M | ﹤0.01% | 3028 |
|
|
2022
Q2 | $4.55M | Sell |
394,970
-204,364
| -34% | -$2.41M | ﹤0.01% | 3503 |
|
|
2022
Q1 | $7.54M | Sell |
599,334
-20,046
| -3% | -$230K | ﹤0.01% | 3168 |
|
|
2021
Q4 | $7.22M | Buy |
619,380
+216,160
| +54% | +$2.65M | ﹤0.01% | 3281 |
|
|
2021
Q3 | $5.26M | Buy |
403,220
+16,822
| +4% | +$217K | ﹤0.01% | 3512 |
|
|
2021
Q2 | $4.97M | Sell |
386,398
-33,150
| -8% | -$379K | ﹤0.01% | 3506 |
|
|
2021
Q1 | $4.69M | Buy |
419,548
+174,020
| +71% | +$1.84M | ﹤0.01% | 3462 |
|
|
2020
Q4 | $2.8M | Sell |
245,528
-117,648
| -32% | -$1.29M | ﹤0.01% | 3650 |
|
|
2020
Q3 | $3.27M | Sell |
363,176
-198,413
| -35% | -$1.97M | ﹤0.01% | 3294 |
|
|
2020
Q2 | $5.79M | Buy |
561,589
+244,812
| +77% | +$2.51M | ﹤0.01% | 2711 |
|
|
2020
Q1 | $3.2M | Sell |
316,777
-87,008
| -22% | -$1.02M | ﹤0.01% | 3096 |
|
|
2019
Q4 | $5.38M | Sell |
403,785
-336,087
| -45% | -$3.71M | ﹤0.01% | 3172 |
|
|
2019
Q3 | $6.35M | Buy |
739,872
+162,948
| +28% | +$1.58M | ﹤0.01% | 2972 |
|
|
2019
Q2 | $6.31M | Buy |
576,924
+279,310
| +94% | +$3.13M | ﹤0.01% | 3009 |
|
|
2019
Q1 | $3.37M | Buy |
297,614
+115,795
| +64% | +$1.29M | ﹤0.01% | 3543 |
|
|
2018
Q4 | $1.58M | Buy |
181,819
+88,396
| +95% | +$1.01M | ﹤0.01% | 4035 |
|
|
2018
Q3 | $1.45M | Sell |
93,423
-142,283
| -60% | -$2.25M | ﹤0.01% | 4223 |
|
|
2018
Q2 | $3.77M | Sell |
235,706
-19,488
| -8% | -$288K | ﹤0.01% | 3423 |
|
|
2018
Q1 | $3.3M | Sell |
255,194
-46,341
| -15% | -$578K | ﹤0.01% | 3457 |
|
|
2017
Q4 | $3.79M | Buy |
301,535
+5,384
| +2% | +$70.3K | ﹤0.01% | 3379 |
|
|
2017
Q3 | $3.91M | Buy |
296,151
+86,334
| +41% | +$1.19M | ﹤0.01% | 3401 |
|
|
2017
Q2 | $3.32M | Buy |
209,817
+19,273
| +10% | +$280K | ﹤0.01% | 3425 |
|
|
2017
Q1 | $2.72M | Buy |
190,544
+128,384
| +207% | +$1.76M | ﹤0.01% | 3593 |
|
|
2016
Q4 | $796K | Sell |
62,160
-140,586
| -69% | -$1.78M | ﹤0.01% | 4498 |
|
|
2016
Q3 | $2.7M | Buy |
202,746
+86,212
| +74% | +$1.01M | ﹤0.01% | 3395 |
|
|
2016
Q2 | $1.28M | Sell |
116,534
-35,443
| -23% | -$346K | ﹤0.01% | 3983 |
|
|
2016
Q1 | $1.39M | Sell |
151,977
-76,627
| -34% | -$632K | ﹤0.01% | 3874 |
|
|
2015
Q4 | $2.22M | Sell |
228,604
-2,175
| -0.9% | -$21K | ﹤0.01% | 3709 |
|
|
2015
Q3 | $2.01M | Sell |
230,779
-51,393
| -18% | -$480K | ﹤0.01% | 3764 |
|
|
2015
Q2 | $2.85M | Buy |
282,172
+264,640
| +1,509% | +$3.08M | ﹤0.01% | 3121 |
|
|
2015
Q1 | $235K | Buy |
17,532
+110
| +0.6% | +$1.44K | ﹤0.01% | 4827 |
|
|
2014
Q4 | $224K | Buy |
17,422
+1,720
| +11% | +$19.7K | ﹤0.01% | 5283 |
|
|
2014
Q3 | $170K | Sell |
15,702
-10,100
| -39% | -$116K | ﹤0.01% | 5530 |
|
|
2014
Q2 | $332K | Sell |
25,802
-24,014
| -48% | -$261K | ﹤0.01% | 5025 |
|
|
2014
Q1 | $513K | Sell |
49,816
-12,747
| -20% | -$143K | ﹤0.01% | 4560 |
|
|
2013
Q4 | $608K | Buy |
62,563
+11,727
| +23% | +$105K | ﹤0.01% | 4586 |
|
|
2013
Q3 | $504K | Sell |
50,836
-21,735
| -30% | -$213K | ﹤0.01% | 4632 |
|
|
2013
Q2 | $604K | Buy |
+72,571
| New | +$880K | ﹤0.01% | 4565 |
|
Other funds holding IRWD
AC
SCM
VPM
VCM
Bank of America's IRWD Position: Q1 2026 in Review
Bank of America reduced its Ironwood Pharmaceuticals (IRWD) stake by 25% in Q1 2026, selling an estimated $11.6M and leaving 8,682,907 shares worth $30.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2021.
Bank of America first reported a position in IRWD in Q2 2013 and has held it in 52 quarters since. The position peaked at $38.8M in Q4 2025. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.
- Bank of America held 8,682,907 shares of Ironwood Pharmaceuticals worth $30.5M as of Q1 2026.
- Bank of America sold 2,838,753 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $11.6M.
- Ironwood Pharmaceuticals made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2021 holding.
- Bank of America first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Bank of America's Ironwood Pharmaceuticals position peaked at $38.8M in Q4 2025.
- 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.